Philipp Ermert
8Patents
3h-index
18Co-inventors
46Inventor score
Filing activity: Jun 5, 2008 → Oct 13, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8288377B2 | Inhibitors of the interaction between MDM2 and p53 | Human Necessities | 21 | Active |
| US9512139B2 | Conformationally constrained, fully synthetic macrocyclic compounds | Chemistry; Metallurgy | 5 | Active |
| US10017481B2 | Conformationally constrained, fully synthetic macrocyclic compounds | Chemistry; Metallurgy | 4 | Active |
| US9695191B2 | Conformationally constrained, fully synthetic macrocyclic compounds | Chemistry; Metallurgy | 3 | Active |
| US9120821B2 | Piperidine/piperazine derivatives | Chemistry; Metallurgy | 0 | Active |
| US9499567B2 | Piperidine/piperazine derivatives | Chemistry; Metallurgy | 0 | Active |
| US8835437B2 | Piperidine/piperazine derivatives | Chemistry; Metallurgy | 0 | Active |
| US9688696B2 | Piperidine/piperazine derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.